Home
About
Services
Partners
Client Portfolio
News
Contact
Boeing lifts industry demand forecast as air show deals roll on
July 17, 2018
Fed’s Powell: ‘Several years’ of strong jobs, low inflation still ahead
July 17, 2018
0
Johnson & Johnson quarterly profit beats on higher pharma unit sales
Published by
Muller&Green
at
July 17, 2018
Categories
RSS
Tags
Johnson & Johnson on Tuesday topped analysts’ estimates for quarterly profit and revenue, driven by higher sales of rare-disease treatments from its acquisition of Actelion and cancer drugs Zytiga and Darzalex.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more